Objective: To evaluate the Primary Care Physician’s (PCPs) knowledge, attitude and clinical behavior in managing patients with BPH, as an input in the review of BPH guideline of Indonesian Urology Association. Material & method: The mailing included a cover letter, questioner consist of 10 questions survey, survey instrument and a post-paid envelope. A 10-questions survey were validated according to BPH guideline by Indonesian Urology Association (IUA). PCPs who work in district health offices and registered in district health office of Indonesian Health Ministry in Bandung, were selected as respondents. Results: 75% of sampled primary care physician working in 71 district health offices responded. 83% of respondent did not know the BPH guideline that had been published by Indonesian Urology Association. Although 88% of PCP’s knew about the symptoms of BPH, only 32% heard about of International Prostate Symptoms score. However, only 13 % were reported applying the symptoms score. Regarding to mandatory examination by the guideline, 64% of PCPs reported performing digital rectal examination, and 47% reported ordering urinalysis test. The recommended test such as PSA and serum creatinine level only asked 24% and 60% by PCPs. Only 21% of PCPs knew about the uroflowmetry but never ordering the test. 47% of PCPs reported using α blockers and 2% using finasteride for treating BPH. The referral was conducted by PCPs mostly due to urinary retention and hematuria. 70% of PCPs would refer the patients to urologist and the others to general surgeon and general internist. Conclusion: Although PCPs play role up to certain extent in diagnosing and managing of BPH, most of them are not interested in looking for reference.
BPH guideline, serum creatinin, urinary retention, hematuria
Lohr KN, Fielt MJ. A provisional instrument for assessing clinical guidelines. In: Filled MJ, Lohr KN, eds. Guidelines for Clinical Practice: From Development to Use. Washington, DC: National Academy Press; 1992. p. 346-410.
Speakman MJ, Kirby RS, Joyce A, Abrams P. Guidelines for the primary care management of male lower urinary tract symptoms. BJU Int 2004; 93: 985-990.
Roehrborn CG, Bartsh G, Kirby RS. Guidelines for diagnosing and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology 2001; 58: 642-50.
Fawzy A, Fontenot C, Guthrie R, Baudier MM. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer. Fam Med 1997; 29: 321-5.
Mary MC, Michael JB, Lin B. Diagnosis and treatment of benign prostatic hyperplasia. Practice pattern of primary care Physicians. J Gen Intern Med 1997; 12: 224-9.
Steven AK, Michael JN, Michael OF. Practical guidelines for the treatment of enlarged prostate in the primary care setting. Available at: http://www.medscape.com/view article/505863_1. Accessed April, 27, 2006.
KMC Verhamme, JP Dieleman, GS Bleumink. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care-the triumph project. European Urology 2002; 42: 323-8.
Schrijvers AJP. Health and health care in the Netherlands. A critical self-assessment of Dutch experts in medical and health sciences. Utrecth: De Tijfstroom; 1997.
Kirby R, Kirby F, Fitzpatrick. Shared care for prostatic diseases. In: The shared care consept. Oxford: ISIS medical media; 1994. p. 1-9.
Michael wong, Foo keong tatt. Urology and the family physician. In: Michael wong, Alfred loh. Guidelines on the shared care program for benign prostatic hyperplasia. Singapore: Singapore general hospital; 2004. p. 56-8.
Hyung Kim, David AB, Scott DS. Practice trends in the management of prostate disease by family practice physician and general internists: an internet-based survey. Urology 2002; 59: 266-71.
Neil Baum, Adam Lipp. PSA for primary care physician. Available at: http:// www.mmhc.com/g/index.cfm. Accessed April, 27, 2006.
Kuritzky, MD. Role of primary care clinicians in the diagnosis and treatment of LUT and BPH. Rev Urol 2004; 6 (9): S53-S59
Pamela D, Robert WR, Robert RB. Managing benign prostatic hyperplasia. Am Fam Physician 2002; 66: 77-84, 87-8.